Impact of atrial fibrillation in hospitalized patients undergoing endoscopic retrograde cholangiopancreatography: A nationwide analysis

Table 4 Outcomes in patients undergoing endoscopic retrograde cholangiopancreatogram: Atrial fibrillation vs no-atrial fibrillation

Study population with ERCP (n = 433245)
	Outcomes	Without AF	With AF (multivariate regression)	P value	With AF (after propensity matching)	P value
1	In-hospital mortality	1.13%	3.82%
	OR	Ref	3.46	< 0.01	3.29	< 0.01
	AOR	Ref	1.93	< 0.01	1.74	< 0.01
2	Mean time to ERCP (days)	2.13	2.94		2.97
	Adjusted coefficient	Ref	+0.8	< 0.01	+0.50	< 0.01
3	Mean length of stay (days)	5.6	8.12
	Adjusted coefficient	Ref	+1.71	< 0.01	+1.56	< 0.01
4	Mean total charge ($)	79963	106017		100359
	Adjusted coefficient ($)	Ref	21209	< 0.01	17972	< 0.01
5	Mean total cost ($)	19214	25534
	Adjusted coefficient ($)	Ref	4869	< 0.01	Not applicable
6	Shock	3.26%	10.27%
	OR	Ref	3.39	< 0.01	3.24	< 0.01
	AOR	Ref	2.17	< 0.01	2.04	< 0.01
7	Sepsis	3.32%	6.30%
	OR	Ref	1.95	< 0.01	1.96	< 0.01
	AOR	Ref	1.34	< 0.01	1.30	< 0.01
8	Intensive care unit admission	2.30%	7.27%
	OR	Ref	3.31	< 0.01	3.08	< 0.01
	AOR	Ref	2.41	< 0.01	2.31	< 0.01
9	Acute kidney injury	12.7%	29.47%
	OR	Ref	2.87	< 0.01	2.76	< 0.01
	AOR	Ref	1.51	< 0.01	1.42	< 0.01
10	Blood transfusion	0.29%	0.49%
	OR	Ref	1.69	< 0.01	1.67	< 0.05
	AOR	Ref	1.37	0.08	1.15	0.57
11	Home discharge	78.2%	48.34%
	OR	Ref	0.26	< 0.01	0.27	< 0.01
	AOR	Ref	0.59	< 0.01	0.62	< 0.01

AF: Atrial fibrillation; AOR: Adjusted odds ratio; ERCP: Endoscopic retrograde cholangiopancreatogram; N: Total number of patients; OR: Odds ratio; Ref: Reference.